Log in to save to my catalogue

Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitar...

Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitar...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7865297

Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitary Tumours

About this item

Full title

Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitary Tumours

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2021-01, Vol.22 (3), p.1076

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Patients harbouring mutations in genes encoding C-type natriuretic peptide (CNP;
) or its receptor guanylyl cyclase B (GC-B,
) suffer from severe growth phenotypes; loss-of-function mutations cause achondroplasia, whereas gain-of-function mutations cause skeletal overgrowth. Although most of the effects of CNP/GC-B on growth are mediated dire...

Alternative Titles

Full title

Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitary Tumours

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7865297

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7865297

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms22031076

How to access this item